In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charité – Universitätsmedizin Berlin give an overview of their work in 2010 – 2011. Research activities at the MDC focus on cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology.
The presentation of the research groups, technology platforms and technology transfer projects provides insight into the research activities of the MDC. “In recent years the scientists of the MDC have again achieved internationally acclaimed results and published them in leading journals,” said Professor Walter Rosenthal, scientific director of the MDC, in his introduction to the research report. In 2010 the MDC ranked 14th on the Thomson Reuters list in the field of molecular biology and genetics, making it the only German research institution to be among the world’s “Top Twenty”.
Furthermore, Professor Rosenthal emphasized the MDC’s extensive participation in excellence clusters and collaborative research centers, the acquisition of eight ERC grants and the award of the Leibniz Prize –the most highly endowed German research prize – to Professor Nikolaus Rajewsky, head of the Berlin Institute for Medical Systems Biology (BIMSB) at the MDC, during the period covered by the report.
“The founding charter of the MDC, which was formulated in 1992, is more relevant than ever,” Professor Rosenthal went on to say. “Its aim is to make laboratory results quickly available to doctors and patients in the hospital – as we say the ʽbench to bedsideʼ approach.” In 2007 the Experimental and Clinical Research Center (ECRC), modeled after Clinical Research Centers (CRC) in the U.S., was founded on Campus Berlin-Buch.
As a joint institution of the MDC and the Charité, the ECRC promotes cooperation between basic scientists and clinical researchers in order to accelerate the transfer of insights gained from laboratory research into medical practice. In the future, according to Prof. Rosenthal, the MDC will take its longstanding and close partnership with the Charité to a new level by developing a common institutional platform. This will ensure that “basic biomedical research and clinical research will benefit even more from each other than in the past.”
The MDC was founded on the Campus Berlin-Buch in 1992. It is a member of the Helmholtz Association of German Research Centres and receives its basic operational funding of approximately 71 million euros a year in a fixed ratio of 90 percent from the Federal Ministry of Education and Research and 10 percent from the state of Berlin. In addition, extramural grants acquired by the researchers are in the two-digit million-euro range each year. At present, approximately 1350 people work at the MDC. These include around 1100 research staff members, of whom around 700 are scientists from Germany and from other countries. Along with its partnership with the Charité, the MDC cooperates closely with the Berlin universities, with the Leibniz-Institut für Molekulare Pharmakologie (FMP), the biotechnology park on Campus Berlin-Buch with its 55 companies and with universities and research institutions inside and outside of Germany.
To receive this new research report, please request a copy from the MDC Press Department.Contact:
Barbara Bachtler | Max-Delbrück-Centrum
Scientists spin artificial silk from whey protein
24.01.2017 | Deutsches Elektronen-Synchrotron DESY
Choreographing the microRNA-target dance
24.01.2017 | UT Southwestern Medical Center
A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Physics and Astronomy
24.01.2017 | Life Sciences
24.01.2017 | Health and Medicine